Endemic Mycoses: What’s New About Old Diseases?

Ilan S. Schwartz, Chris Kenyon, George Richard Thompson

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

Infections with geographically constrained dimorphic fungi cause the endemic mycoses, which include blastomycosis, coccidioidomycosis, emmonsiosis, histoplasmosis, paracoccidioidomycosis, sporotrichosis, and penicilliosis. In the last 5 years, our understanding of the epidemiology, diagnostics, and to a lesser extent management of these diseases has advanced. Specifically, the application of molecular techniques for genotyping fungal pathogens has resulted in the recognition of cryptic species within several genera, including Blastomyces, and Paracoccidioides; the reclassification of Penicillium marneffei, the agent of penicilliosis, to the genus Talaromyces; and the global emergence of dimorphic fungi of the genus Emmonsia, cause disease in immunocompromised persons. New and refined diagnostic tests are available based on the detection of circulating antigens and antibodies, mass spectrometry, and targeted gene amplification. In contrast, the development of new therapeutic options remains stalled, although isavuconazole may hold promise. Finally, advances have been made in the prospect of viable vaccines for preventing animal and human disease.

Original languageEnglish (US)
Pages (from-to)71-80
Number of pages10
JournalCurrent Clinical Microbiology Reports
Volume3
Issue number2
DOIs
StatePublished - Jun 1 2016

Fingerprint

Mycoses
Talaromyces
Fungi
Genotyping Techniques
Chrysosporium
Blastomyces
Paracoccidioides
Sporotrichosis
Blastomycosis
Paracoccidioidomycosis
Coccidioidomycosis
Histoplasmosis
Animal Diseases
Gene Amplification
Penicillium
Disease Management
Routine Diagnostic Tests
Mass Spectrometry
Epidemiology
Vaccines

Keywords

  • Blastomycosis
  • Coccidioidomycosis
  • Emmonsiosis
  • Histoplasmosis
  • Paracoccidioidomycosis
  • Penicilliosis
  • Sporotrichosis
  • Talaromyces

ASJC Scopus subject areas

  • Infectious Diseases
  • Microbiology (medical)

Cite this

Endemic Mycoses : What’s New About Old Diseases? / Schwartz, Ilan S.; Kenyon, Chris; Thompson, George Richard.

In: Current Clinical Microbiology Reports, Vol. 3, No. 2, 01.06.2016, p. 71-80.

Research output: Contribution to journalReview article

Schwartz, Ilan S. ; Kenyon, Chris ; Thompson, George Richard. / Endemic Mycoses : What’s New About Old Diseases?. In: Current Clinical Microbiology Reports. 2016 ; Vol. 3, No. 2. pp. 71-80.
@article{d23b961f3ff54bc89375b9beb07f22c6,
title = "Endemic Mycoses: What’s New About Old Diseases?",
abstract = "Infections with geographically constrained dimorphic fungi cause the endemic mycoses, which include blastomycosis, coccidioidomycosis, emmonsiosis, histoplasmosis, paracoccidioidomycosis, sporotrichosis, and penicilliosis. In the last 5 years, our understanding of the epidemiology, diagnostics, and to a lesser extent management of these diseases has advanced. Specifically, the application of molecular techniques for genotyping fungal pathogens has resulted in the recognition of cryptic species within several genera, including Blastomyces, and Paracoccidioides; the reclassification of Penicillium marneffei, the agent of penicilliosis, to the genus Talaromyces; and the global emergence of dimorphic fungi of the genus Emmonsia, cause disease in immunocompromised persons. New and refined diagnostic tests are available based on the detection of circulating antigens and antibodies, mass spectrometry, and targeted gene amplification. In contrast, the development of new therapeutic options remains stalled, although isavuconazole may hold promise. Finally, advances have been made in the prospect of viable vaccines for preventing animal and human disease.",
keywords = "Blastomycosis, Coccidioidomycosis, Emmonsiosis, Histoplasmosis, Paracoccidioidomycosis, Penicilliosis, Sporotrichosis, Talaromyces",
author = "Schwartz, {Ilan S.} and Chris Kenyon and Thompson, {George Richard}",
year = "2016",
month = "6",
day = "1",
doi = "10.1007/s40588-016-0034-6",
language = "English (US)",
volume = "3",
pages = "71--80",
journal = "Current Clinical Microbiology Reports",
issn = "2196-5471",
publisher = "Springer International Publishing AG",
number = "2",

}

TY - JOUR

T1 - Endemic Mycoses

T2 - What’s New About Old Diseases?

AU - Schwartz, Ilan S.

AU - Kenyon, Chris

AU - Thompson, George Richard

PY - 2016/6/1

Y1 - 2016/6/1

N2 - Infections with geographically constrained dimorphic fungi cause the endemic mycoses, which include blastomycosis, coccidioidomycosis, emmonsiosis, histoplasmosis, paracoccidioidomycosis, sporotrichosis, and penicilliosis. In the last 5 years, our understanding of the epidemiology, diagnostics, and to a lesser extent management of these diseases has advanced. Specifically, the application of molecular techniques for genotyping fungal pathogens has resulted in the recognition of cryptic species within several genera, including Blastomyces, and Paracoccidioides; the reclassification of Penicillium marneffei, the agent of penicilliosis, to the genus Talaromyces; and the global emergence of dimorphic fungi of the genus Emmonsia, cause disease in immunocompromised persons. New and refined diagnostic tests are available based on the detection of circulating antigens and antibodies, mass spectrometry, and targeted gene amplification. In contrast, the development of new therapeutic options remains stalled, although isavuconazole may hold promise. Finally, advances have been made in the prospect of viable vaccines for preventing animal and human disease.

AB - Infections with geographically constrained dimorphic fungi cause the endemic mycoses, which include blastomycosis, coccidioidomycosis, emmonsiosis, histoplasmosis, paracoccidioidomycosis, sporotrichosis, and penicilliosis. In the last 5 years, our understanding of the epidemiology, diagnostics, and to a lesser extent management of these diseases has advanced. Specifically, the application of molecular techniques for genotyping fungal pathogens has resulted in the recognition of cryptic species within several genera, including Blastomyces, and Paracoccidioides; the reclassification of Penicillium marneffei, the agent of penicilliosis, to the genus Talaromyces; and the global emergence of dimorphic fungi of the genus Emmonsia, cause disease in immunocompromised persons. New and refined diagnostic tests are available based on the detection of circulating antigens and antibodies, mass spectrometry, and targeted gene amplification. In contrast, the development of new therapeutic options remains stalled, although isavuconazole may hold promise. Finally, advances have been made in the prospect of viable vaccines for preventing animal and human disease.

KW - Blastomycosis

KW - Coccidioidomycosis

KW - Emmonsiosis

KW - Histoplasmosis

KW - Paracoccidioidomycosis

KW - Penicilliosis

KW - Sporotrichosis

KW - Talaromyces

UR - http://www.scopus.com/inward/record.url?scp=85019556880&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019556880&partnerID=8YFLogxK

U2 - 10.1007/s40588-016-0034-6

DO - 10.1007/s40588-016-0034-6

M3 - Review article

AN - SCOPUS:85019556880

VL - 3

SP - 71

EP - 80

JO - Current Clinical Microbiology Reports

JF - Current Clinical Microbiology Reports

SN - 2196-5471

IS - 2

ER -